Legal status · United States
Is BPC-157 legal in the United States?
No. BPC-157 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
BPC-157 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Not a dietary supplement; flagged by FDA for compounding. |
| FDA approval status | Not FDA-approved. Removed from Category 2 (April 2026); PCAC voted 8 to 6 to recommend for compounding (July 2026); awaiting FDA rulemaking |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the BPC-157 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing BPC-157 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What BPC-157 is
A pentadecapeptide studied extensively in animal models for tendon, ligament, muscle, and gut healing. Human evidence remains limited.
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It has been studied heavily in rodent models for regenerative effects on connective tissue and the gastrointestinal tract.
Mechanism: In animal studies it appears to promote angiogenesis, modulate the nitric oxide system, and upregulate growth factor signaling involved in tissue repair. Human mechanistic data are limited.
Regulatory history: Not FDA-approved. Removed from Category 2 (April 2026); PCAC voted 8 to 6 to recommend for compounding (July 2026); awaiting FDA rulemaking
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for BPC-157 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
BPC-157 in other countries
Frequently asked questions
Is BPC-157 legal in the United States?
No. BPC-157 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary. Note: Not a dietary supplement; flagged by FDA for compounding.
Can I buy BPC-157 in the United States?
No approved product exists to buy. In the United States BPC-157 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not a dietary supplement; flagged by FDA for compounding.
Is BPC-157 FDA approved?
No. FDA status: Not FDA-approved. Removed from Category 2 (April 2026); PCAC voted 8 to 6 to recommend for compounding (July 2026); awaiting FDA rulemaking. Current US classification: "Not approved; research use only". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for BPC-157 live on its compound profile.
BPC-157 profileThis page is general information about the regulatory status of BPC-157 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.